Cleared Traditional

K782153 - IMPRESSION TRAY, MDDS CUSTOM

K782153 is an FDA 510(k) clearance for IMPRESSION TRAY, manufactured by Chayet and Sonnenrich, P.C.. The device is a Class 1 Dental device with product code EBH cleared through the Traditional 510(k) pathway after a 62-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1979
Decision
62d
Days
Class 1
Risk

K782153 is an FDA 510(k) clearance for the IMPRESSION TRAY, MDDS CUSTOM. Classified as Material, Impression Tray, Resin (product code EBH), Class I - General Controls.

Submitted by Chayet and Sonnenrich, P.C. (Walker, US). The FDA issued a Cleared decision on February 26, 1979 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3670 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Chayet and Sonnenrich, P.C. devices

FDA 510(k) Submission Details - K782153

510(k) Number K782153 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 1978
Decision Date February 26, 1979
Days to Decision 62 days
Submission Type Traditional
Review Panel Dental (DE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 128d · This submission: 62d
Pathway characteristics
Predicate-based equivalence.

EBH Device Classification - Class 1, General Controls

Product Code EBH Material, Impression Tray, Resin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.3670
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.